Hematology, Transfusion and Cell Therapy
ISSN: 2531-1379
Hematology, Transfusion and Cell Therapy é uma publicação científica trimestral da Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE) e Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).
A Hematology, Transfusion and Cell Therapy publica artigos originais, artigos de revisão e relatos de caso relacionados com várias temáticas da área de hematologia e hemoterapia. Até 2017, a revista foi publicada sob o título Revista Brasileira de Hematologia e Hemoterapia.
ISSN print: 2531-1379
ISSN online: 2531-1387
Publicado por Elsevier Editora Ltda, Rio de Janeiro, Brasil.
Indexada em:
LILACS, SciELO Brazil, Scopus, and PubMed/PMC
Ver maisSiga-nos no:
CiteScore 2019
O CiteScore mede as citações médias recebidas por documento publicado. Mais informação
CiteScore 2019
1,4
SJR é uma métrica de prestígio baseada na idéia de que todas as citações não são iguais. SJR utiliza um algoritmo similar ao page rank do Google; é uma medida quantitativa e qualitativa ao impacto de uma publicação.
SJR
0,324
SNIP permite comparar o impacto de revistas de diferentes campos temáticos, corrigindo as diferenças na probabilidade de ser citado que existe entre revistas de distintas matérias.
SNIP
0,635
Ocultar
Número
Vol. 42. Núm. 2.Páginas 103-194 (April - June 2020)
Special content
Special Content
Special article
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
Guilherme Fleury Perini, Thais Fischer, Rafael Dezen Gaiolla, Talita Bueno Rocha, Marcelo Bellesso, Larissa Lane Cardoso Teixeira, Marcia Torresan Delamain, Adriana Alves de Souza Scheliga, Glaciano Nogueira Ribeiro, Jorge Vaz Neto, Otávio Cesar Carvalho Guimaraes Baiocchi, André Neder Ramires Abdo, Celso Arrais-Rodrigues, Laura M. Fogliatto, Ricardo de Sá Bigni, Rony Schaffel, Irene Biasoli, Juliana Pereira, Samir Kanaan Nabhan, Cármino Antônio de Souza, Carlos Sérgio Chiattone
hematol Transfus Cell Ther. 2020;42:103-10
Open access
Special Content
Special scientific comments
COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals
Marcia Garnica, Angelo Maiolino
hematol Transfus Cell Ther. 2020;42:111-2
Open access
COVID-19 convalescent plasma transfusion
Dante Mário Langhi, Gil Cunha De Santis, José Orlando Bordin
hematol Transfus Cell Ther. 2020;42:113-5
Open access
Special Content
Letter to the editor
Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
Giuseppe Lippi, Camilla Mattiuzzi
hematol Transfus Cell Ther. 2020;42:116-7
Open access
Original articles
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
Edvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, Rosane Bittencourt, Jorge Vaz Pinto Neto, Lais Sousa, Rodrigo Santucci, Roberto José Pessoa Magalhães, Gilberto Colli, Renata Ferreira Marques Nunes, Glaciano Ribeiro, Jandir Nicacio, Karla Richter Zanella, Jose Mauro Kutner, Andre Magalhaes, Danielle Leao, Abrahão Elias Hallack Neto, Walter Braga, Emanuella G Souza, Antonio Julio A.M. Guimaraes, Giovanna Steffenello Durigon, Dani Laks, Angelo Maiolino, Vania Tietsche de Moraes Hungria
hematol Transfus Cell Ther. 2020;42:118-24
Open access
Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients
Ashish Maheshwari, Meenu Bajpai, Gopal Kumar Patidar
hematol Transfus Cell Ther. 2020;42:125-8
Open access
Profile of blood donations with a positive serology in Southern Brazil
Bruna Jaques, Patrícia Cavalcanti de Albuquerque Saldanha, Ana Carolina Rabello de Moraes
hematol Transfus Cell Ther. 2020;42:129-33
Open access
Stability of refrigerated whole blood samples for osmotic fragility test
Gian Luca Salvagno, Davide Demonte, Francesco Dima, Chiara Bovo, Giuseppe Lippi
hematol Transfus Cell Ther. 2020;42:134-8
Open access
Bacterial meningitis in patients with sickle cell anemia in Salvador, Bahia, Brazil: a report on ten cases
Francine Chenou, Jailton Azevedo, Helena Ferreira Leal, Marilda de Souza Gonçalves, Joice Neves Reis
hematol Transfus Cell Ther. 2020;42:139-44
Open access
Prevalence of hemoglobin abnormalities in an apparently healthy population in Benin
Alban Zohoun, Tatiana Baglo Agbodande, Lutécia Zohoun, Ludovic Anani
hematol Transfus Cell Ther. 2020;42:145-9
Open access
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
Virgínia Picanço-Castro, Pablo Diego Moço, Amanda Mizukami, Leticia Delfini Vaz, Marcelo de Souza Fernandes Pereira, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Aline de Sousa Bomfim, Mario Soares de Abreu Neto, Kelen Cristina Ribeiro Malmegrim, Kamilla Swiech, Dimas Tadeu Covas
hematol Transfus Cell Ther. 2020;42:150-8
Open access
Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
Priscilla Cury de Camargo Cury, Fabiana Higashi, Flávia Fernandes Silva Zacchi, Renata Bacic Palhares, Adriana Alvares Quero, Ana Luiza Miranda Silva Dias, Edvan de Queiroz Crusoé, Vania Tietsche de Moraes Hungria
hematol Transfus Cell Ther. 2020;42:159-63
Open access
Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
Cesar de Almeida-Neto, Vanderson Rocha, Frederico Rafael Moreira, Debora Toshie Hamasaki, Madson Correia de Farias, Ana Maria Arrifano, Steven S. Witkin, Alfredo Mendrone-Junior
hematol Transfus Cell Ther. 2020;42:164-165.e5
Open access
Oral health status of patients with multiple myeloma
Édila Figuerêdo Feitosa, Roberto José Pessoa Magalhães, Carlos Augusto de Melo Barbosa, Fabio Ribeiro Guedes, Angelo Maiolino, Sandra Regina Torres
hematol Transfus Cell Ther. 2020;42:166-72
Open access
Case reports
Trapping of platelets in leukocyte reduction chamber leads to failure of plateletpheresis procedure: a rare troubleshooting during apheresis
Dibyajyoti Sahoo, Satya Prakash, Somnath Mukherjee, Gopal Krushna Ray
hematol Transfus Cell Ther. 2020;42:173-5
Open access
Organizing pneumonia in a patient with hodgkin’s lymphoma and large B cell lymphoma: a rare association
Jaume Bordas-Martinez, Mercè Gasa, Eva Domingo-Domènech, Vanesa Vicens-Zygmunt
hematol Transfus Cell Ther. 2020;42:176-9
Open access
Diffuse large B-cell lymphoma in blood and bone marrow: a rare presentation of leukemic phase at diagnosis
Pooja K. Suresh, Sridevi Hanaganahalli Basavaiah, Mrigank Goel, Sanyo Dsouza, Santosh Rai
hematol Transfus Cell Ther. 2020;42:180-3
Open access
Histiocytic sarcoma of the lymph node: a rare and aggressive hematolymphoid malignancy
Goel Deepa, Verma Kamal, Vasdev Nandini, Sinha Noaline, Subodh Chandra Pande
hematol Transfus Cell Ther. 2020;42:184-7
Open access
Images in clinical hematology
Massive bone marrow infiltration by Streptococcus pyogenes during severe community pneumonia
Tayrine Fernanda Micheli de Oliveira, Pollyana Cristina Bernardes Valize, Leonardo Rodrigues de Oliveira
hematol Transfus Cell Ther. 2020;42:188-9
Open access
Letters to the editor
Is it time to use hematopoietic stem cell transplantation for severe and refractory crohn's disease?
Milton Artur Ruiz, Roberto Luiz Kaiser Junior, Luiz Gustavo de Quadros
hematol Transfus Cell Ther. 2020;42:190-1
Open access
Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
Camila Peña, Pablo Villegas, María Elena Cabrera
hematol Transfus Cell Ther. 2020;42:192-3
Open access
Erratum
Erratum on “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”
Sergio Augusto Buzian Brasil, Carolina Colaço, Tomas Barrese, Roberto P. Paes, Cristina Bortolheiro, Rodolfo Delfini Cançado
hematol Transfus Cell Ther. 2020;42:194
Open access
Conteúdo especial sobre COVID-19
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.
Idiomas
Hematology, Transfusion and Cell Therapy